Search Results

You are looking at 71 - 80 of 250 items for :

  • "Acute myeloid leukemia" x
  • Refine by Access: All x
Clear All
Full access

JNCCN CE Offerings

Acute Myeloid Leukemia: Ready for Prime Time? Expiration Date: 8/7/13 Androgen Deprivation Therapy: Minimizing Exposure and Mitigating Side Effects Expiration Date: 9/5/13 Use of Endobronchial Ultrasound and Endoscopic Ultrasound to Stage the

Full access

Six (or More) Drugs in Search of a Mechanism: DNA Methyltransferase and Histone Deacetylase Inhibitors in the Treatment of Myelodysplastic Syndromes

Steven D. Gore

of gene expression by 5-Aza-2′-deoxycytidine in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) but not epithelial cells by DNA-methylation-dependent and -independent mechanisms . Leukemia 2005 ; 19 : 103 – 111 . 8

Full access

NCCN Task Force Report: Molecular Markers in Leukemias and Lymphomas

Jerald P. Radich, Andrew D. Zelenetz, Wing C. Chan, Carlo M. Croce, Myron S. Czuczman, Harry P. Erba, Sandra J. Horning, Jane Houldsworth, B. Douglas Smith, David S. Snyder, Hema M. Sundar, Meir Wetzler, and Jane N. Winter

; 112 : Abstract 1071 . 94 Mrozek K Marcucci G Paschka P . Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular

Full access

The Role of Flow Cytometry in Myelodysplastic Syndromes

Michael R. Loken and Denise A. Wells

S Safford M . Flow cytometric characterization of acute myeloid leukemia. Part 1: significance of light scattering properties . Leukemia 1991 ; 5 : 315 – 321 . 9. Hurwitz CA Loken MR Graham ML . Asynchronous antigen expression in B

Full access

Impact of Age and Comorbidity in Myelodysplastic Syndromes

Reinhard Stauder, Thomas Nösslinger, Michael Pfeilstöcker, Wolfgang R. Sperr, Friedrich Wimazal, Otto Krieger, and Peter Valent

and acute myeloid leukemia in Tyrol: incidence and distribution [abstract] . Onkologie 2003 ; 23 ( Suppl 5 ): S121 . Abstract P683 . 11. Germing U Strupp C Kundgen A . No increase in age-specific incidence of myelodysplastic syndromes

Full access

HSR24-159: Relationship Between Durable Transfusion Independence (TI) and Survival Outcomes in Patients (Pts) With Lower-Risk Myelodysplastic Syndrome (LR-MDS): An Analysis From US Health Insurance Claims Data

Rami S. Komrokji, Nishan Sengupta, Dylan Supina, Shyamala Navada, Ravi Potluri, Rohit Tyagi, Timothy Werwath, Zhouer Xie, Eric Padron, and David Sallman

.1, D46.9, D46.A, and D46.B) from Oct 2015 to Mar 2023. No diagnosis of MDS/acute myeloid leukemia (AML) or use of higher-risk MDS or AML medication before their respective index diagnosis dates were allowed. Lines of treatment were determined by the

Full access

CLO24-084: Myeloid Sarcoma in a Patient With Marfan Syndrome

Nitya Batra, Atulya Aman Khosla, Shyam Poudel, and Daniel Ezekwudo

myeloid leukemia (AML), however, it can occur solitarily or coexist with myelodisplastic syndrome (MDS) and other myeloproliferative neoplasms. Most common isolated sites are skin, bone, soft tissues and lymph nodes. We present a rare gastrointestinal

Full access

QIM23-131: A Retrospective Review of Myelodysplastic Syndrome Management (MDS) at Watson Clinic LLP: From Diagnosis to Primary Course of Treatment

Shane Burke, Galina Vugman, Noreen McGowan, and Michelle Sharrett

Comprehensive Cancer Network (NCCN) Guidelines recommend treatment patterns based on risk of progression into Acute Myeloid Leukemia (AML). Adherence to these guidelines improves survival rates in patients with MDS. An MDS work-up should include an extensive

Full access

CGE23-071: Real World Data on the Implementation of a Hereditary Hematological Myeloid Malignancy Workflow: Experience of a Single Academic Medical Center

Moon Ley Tung, Athena Puski, Jennifer L Stinson, Nicole Huser, and Madeline VanDerGraaf

Background: Hereditary myeloid malignancy syndromes (HMMS) are increasingly recognized in adult patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML). Timely diagnosis of HMMS is critical to ensure appropriate bone marrow

Full access

QIM23-137: Improving Hematology-Oncology Education in Internal Medicine Residency—A Single Institution Quality Improvement Project

Georgio Medawar, Jessica Khoury, Antoine Salloum, and John Miskovsky

prior and after a 5-lecture series. The topics covered were acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), lung cancer, colon cancer, and breast cancer. The lectures were prepared based on National Comprehensive Cancer Center (NCCN